Increased Risk of Chronic Disease Due to Domoic Acid Exposure with Age

随着年龄的增长,软骨藻酸暴露导致慢性病的风险增加

基本信息

  • 批准号:
    1839041
  • 负责人:
  • 金额:
    $ 97.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

Domoic acid (DA) is a toxin produced by a type of harmful algal bloom. Domoic acid accumulates in seafood products and can harm marine mammals and humans who consume contaminated shellfish. At high doses, DA is responsible for the neurotoxic illness known as amnesic shellfish poisoning (ASP), with clinical symptoms that include seizures, memory loss, coma, and death. The effects of chronic exposure to lower doses are less well understood. Recent seafood consumption studies by this research team revealed that some recreational harvesters exceeded the current regulated dose limit and/or were chronically exposed to DA weekly for at least six consecutive months and that the majority of this group is over 60 years of age. Aging is the single greatest risk factor for multiple chronic diseases, including those affecting brain, heart, and kidney function, all of which are also targets of DA toxicity. This study will investigate how the effects of domoic acid exposure change with age. As ocean conditions change, exposure to DA through seafood consumption is likely to increase as a result of increased frequency and severity of toxin producing blooms. Thus a better understanding of the effect of DA exposure on the risk of developing chronic disease and the mechanisms underlying long term health problems, especially in the elderly population, is critical for better management of these risks by regulatory bodies and improved communication with stakeholders. The research is jointly supported by NSF and by the National Institute for Environmental Health Sciences (NIEHS).The study has three specific aims. First, in order to test the hypothesis that aging increases susceptibility to acute DA toxicity the investigators will measure the effects of acute symptomatic DA exposure on cognitive, cardiac and renal function in young and old mice. Following an acute symptomatic exposure, they will quantify tissue pathology and dysfunction in three systems with known DA induced pathology - cognitive, cardiac, and kidney systems. Second, in order to test the hypothesis that aging increases the susceptibility to chronic DA toxicity they will measure the effects of chronic low-level DA exposure on cognitive, cardiac and renal function in young and old mice. The investigators have previously demonstrated that chronic low-level DA exposure caused reversible cognitive deficits. However, whether aging affects the susceptibility to and reversibility of chronic DA toxicity to cognitive, cardiac and renal function has not been examined. Finally, in order to test the hypothesis that mitochondrial oxidative stress underlies chronic DA toxicity in cognitive, cardiac and renal systems they will use the chronic DA exposure paradigm (aim 2) in a mouse model (mCAT) overexpressing catalase, a key antioxidant enzyme, in the mitochondria.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
软骨藻酸(DA)是由一种有害藻华产生的毒素。软骨藻酸在海产品中积累,可能会伤害海洋哺乳动物和食用受污染贝类的人类。在高剂量下,DA会导致被称为遗忘性贝类中毒(ASP)的神经毒性疾病,临床症状包括癫痫发作,记忆丧失,昏迷和死亡。长期接触较低剂量的影响还不太清楚。该研究小组最近的海鲜消费研究显示,一些休闲捕捞者超过了目前的规定剂量限制和/或每周长期暴露于DA至少连续六个月,并且该组中的大多数年龄超过60岁。衰老是多种慢性疾病的最大风险因素,包括影响大脑、心脏和肾功能的疾病,所有这些疾病也是DA毒性的目标。本研究将调查软骨藻酸暴露的影响如何随年龄变化。随着海洋条件的变化,由于产生毒素的水华的频率和严重程度增加,通过食用海鲜接触DA的可能性也会增加。因此,更好地了解DA暴露对慢性疾病风险的影响以及长期健康问题的潜在机制,特别是在老年人群中,对于监管机构更好地管理这些风险以及改善与利益相关者的沟通至关重要。这项研究是由美国国家科学基金会和国家环境健康科学研究所(NIEHS)共同支持的。首先,为了检验衰老增加对急性DA毒性的易感性这一假设,研究人员将测量急性症状性DA暴露对年轻和老年小鼠认知、心脏和肾功能的影响。在急性症状暴露后,他们将量化已知DA诱导病理学的三个系统中的组织病理学和功能障碍-认知,心脏和肾脏系统。其次,为了检验衰老增加对慢性DA毒性的易感性这一假设,他们将测量慢性低水平DA暴露对年轻和老年小鼠认知、心脏和肾功能的影响。研究人员先前已经证明,慢性低水平DA暴露会导致可逆的认知缺陷。然而,是否老化影响敏感性和可逆性的认知,心脏和肾功能的慢性DA毒性尚未检查。最后,为了检验线粒体氧化应激是认知、心脏和肾脏系统中慢性DA毒性的基础的假设,他们将在过表达过氧化氢酶(一种关键的抗氧化酶)的小鼠模型(mCAT)中使用慢性DA暴露范例(目的2),该奖项反映了NSF的法定使命,并通过使用基金会的智力价值进行评估,更广泛的影响审查标准。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Discovery of a Potential Human Serum Biomarker for Chronic Seafood Toxin Exposure Using an SPR Biosensor
  • DOI:
    10.3390/toxins11050293
  • 发表时间:
    2019-05-01
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Lefebvre, Kathi A.;Yakes, Betsy Jean;Grattan, Lynn
  • 通讯作者:
    Grattan, Lynn
Age and Sex as Determinants of Acute Domoic Acid Toxicity in a Mouse Model.
  • DOI:
    10.3390/toxins15040259
  • 发表时间:
    2023-04-01
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    Hendrix AM;Lefebvre KA;Bowers EK;Stuppard R;Burbacher T;Marcinek DJ
  • 通讯作者:
    Marcinek DJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Marcinek其他文献

Acute Oxidative Stress Reduces in Vivo Coupling of Oxidative Phosphorylation Throughout Life: a Multi-Modal in Vivo Spectroscopy Approach
  • DOI:
    10.1016/j.freeradbiomed.2011.10.432
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael Siegel;Shane Kruse;Gary Knowels;David Marcinek
  • 通讯作者:
    David Marcinek
Inducible and reversible SOD2 knockdown in mouse skeletal muscle drives impaired pyruvate oxidation and metabolic inflexibility
小鼠骨骼肌中可诱导且可逆的 SOD2 敲低导致丙酮酸氧化受损和代谢灵活性下降
  • DOI:
    10.1016/j.freeradbiomed.2024.10.185
  • 发表时间:
    2024-11-01
  • 期刊:
  • 影响因子:
    8.200
  • 作者:
    Ethan Ostrom;Rudy Stuppard;Aurora Mattson-Hughes;Gerald Shadel;David Marcinek
  • 通讯作者:
    David Marcinek
290 - Age-Associated Changes in Oxidative Status Affect Exercise Redox Signaling
  • DOI:
    10.1016/j.freeradbiomed.2015.10.339
  • 发表时间:
    2015-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Philip Kramer;Matt Campbell;Jicheng Duan;Weijun Qian;David Marcinek
  • 通讯作者:
    David Marcinek
Fiber Type Determines Mitochondrial Response To Oxidative Stress With Age
  • DOI:
    10.1016/j.freeradbiomed.2011.10.424
  • 发表时间:
    2011-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shane Edward Kruse;Michael Siegel;David Marcinek
  • 通讯作者:
    David Marcinek

David Marcinek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Marcinek', 18)}}的其他基金

A novel antibody based biomarker for toxicity of chronic domoic acid exposure
一种基于抗体的新型生物标志物,用于检测慢性软骨藻酸暴露的毒性
  • 批准号:
    1314088
  • 财政年份:
    2013
  • 资助金额:
    $ 97.84万
  • 项目类别:
    Continuing Grant

相似国自然基金

The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
  • 批准号:
    71903144
  • 批准年份:
    2019
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
  • 批准号:
    81800239
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
  • 批准号:
    81771232
  • 批准年份:
    2017
  • 资助金额:
    54.0 万元
  • 项目类别:
    面上项目
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
  • 批准号:
    81260024
  • 批准年份:
    2012
  • 资助金额:
    50.0 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Inequality, infections and chronic disease in England: the interaction of risk factors and the dynamics of transmission
英国的不平等、感染和慢性病:危险因素和传播动态的相互作用
  • 批准号:
    MR/X033260/1
  • 财政年份:
    2024
  • 资助金额:
    $ 97.84万
  • 项目类别:
    Fellowship
Trustworthy Artificial Intelligence for Personalised Risk Assessment in Chronic Heart Failure
值得信赖的人工智能,用于慢性心力衰竭的个性化风险评估
  • 批准号:
    10078557
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
    EU-Funded
Development and performance of a model combining a polygenic risk score and biopsychosocial measures to predict the transition of acute to chronic low back pain
结合多基因风险评分和生物心理社会测量的模型的开发和性能,以预测急性腰痛向慢性腰痛的转变
  • 批准号:
    478821
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
    Operating Grants
Anti-Müllerian hormone and cardiovascular risk in males with chronic kidney disease: A protocol.
患有慢性肾病的男性的抗苗勒氏管激素和心血管风险:一个方案。
  • 批准号:
    481028
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
  • 批准号:
    493118
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
Integrating Genomic Risk Assessment for Chronic Disease Management in a Diverse Population
整合基因组风险评估以进行不同人群的慢性病管理
  • 批准号:
    10852376
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
The impact of a culturally-based live music intervention on the metabolites and metabolic pathways associated with chronic stress and the risk of preterm birth in Black women
基于文化的现场音乐干预对与慢性压力相关的代谢物和代谢途径的影响以及黑人女性早产风险
  • 批准号:
    10559006
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
Sleep and circadian rhythm disturbances as risk and progression factors for multiple chronic pain conditions
睡眠和昼夜节律紊乱是多种慢性疼痛的风险和进展因素
  • 批准号:
    10733999
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
  • 批准号:
    10644253
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
Identifying genetic drivers of circulating metabolites associated with cardiac risk in pediatric chronic kidney disease
识别与儿童慢性肾病心脏风险相关的循环代谢物的遗传驱动因素
  • 批准号:
    10723371
  • 财政年份:
    2023
  • 资助金额:
    $ 97.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了